Table 5

Relative prevalence of various risk factors with increasing age in males and females presented as univariate and adjusted odds ratios and 95% confidence intervals

Variables

Age group

Univariate odds ratios

Adjusted for body mass index

Adjusted for waist circumference

Adjusted for waist hip ratio


Males


Smoking

15–19

1.0

1.0

1.0

1.0


20–29

5.3 (3.6–7.0)

--

--

--


30–39

16.0 (10.5–21.5)

--

--

--


Body mass index ≥ 25 kg/m2

15–19

1.0

--

1.0

1.0


20–29

1.6 (0.9–2.7)

--

--

--


30–39

7.1 (4.5–11.2)

--

--

--


Waist:hip ratio > 0.9

15–19

1.0

1.0

--

--


20–29

4.5 (2.7–7.6)

--

--

--


30–39

21.1 (12.9–34.2)

--

--

--


Hypertension

15–19

1.0

1.0

1.0

1.0


20–29

2.6 (1.2–5.8)

1.7 (0.7–3.9)

1.1 (0.4–2.8)

1.3 (0.5–3.2)


30–39

13.0 (6.9–24.6)

7.4 (3.7–14.8)

3.4 (1.5–7.5)

4.3 (1.9–9.5)


LDL cholesterol ≥ 130 mg/dl

15–19

1.0

1.0

1.0

1.0


20–29

6.4 (3.3–12.2)

5.9 (3.0–11.5)

4.7 (2.4–9.4)

5.4 (2.7–10.9)


30–39

27.4 (15.2–49.6)

22.2 (11.7–42.0)

16.7 (8.2–34.1)

20.1 (9.8–41.3)


Triglycerides ≥ 150 mg/dl

15–19

1.0

1.0

1.0

1.0


20–29

3.7 (1.9–7.1)

2.7 (1.4–5.4)

2.4 (1.2–4.8)

2.6 (1.3–5.1)


30–39

24.2 (13.9–42.1)

19.9 (10.9–36.1)

15.8 (8.2–30.8)

16.8 (8.6–32.6)


HDL cholesterol < 40 mg/dl

15–19

1.0

1.0

1.0

1.0


20–29

2.4 (1.5–3.8)

2.4 (1.5–3.9)

1.9 (1.2–3.3)

1.7 (1.0–2.9)


30–39

15.8 (10.2–24.5)

15.1 (9.3–24.7)

12.9 (7.4–22.6)

10.9 (6.4–18.9)


Total: HDL cholesterol > 4.5

15–19

1.0

1.0

1.0

1.0


20–29

1.6 (1.4–1.9)

1.5 (1.3–1.8)

1.4 (1.1–1.7)

1.4 (1.2–1.7)


30–39

37.9 (22.5–63.9)

32.7 (18.6–57.5)

27.9 (14.8–52.4)

26.8 (14.3–50.3)


Diabetes

15–19

1.0

1.0

1.0

1.0


20–29

4.0 (0.3–64.5)

4.2 (0.3–69.9)

2.6 (1.0–72.3)

2.4 (0.9–67.0)


30–39

50.7 (6.4–403.4)

27.8 (3.2–242.7)

26.2 (1.9–365.8)

19.9 (1.2–336.1)


Metabolic syndrome

15–19

1.0

1.0

1.0

1.0


20–29

37.7 (4.8–298.2)

20.7 (2.5–171.7)

14.3 (1.6–128.4)

17.3 (2.1–148.5)


30–39

168.5 (22.8–1247.1)

95.6 (12.3–741.5)

62.9 (6.4–621.3)

59.1 (6.2–568.1)


Females


Smoking

15–19

1.0

1.0

1.0

1.0


20–29

1.0

--

--

--


30–39

6.3 (5.5–7.1)

--

--

--


Body mass index ≥ 25 kg/m2

15–19

1.0

1.0

1.0

1.0


20–29

0.8 (0.5–1.4)

--

--

--


30–39

11.3 (7.3–11.5)

--

--

--


Waist:hip ratio > 0.8

15–19

1.0

1.0

1.0

1.0


20–29

3.1 (2.2–4.3)

--

--

--


30–39

17.2 (11.0–26.8)

--

--

--


Hypertension

15–19

1.0

1.0

1.0

1.0


20–29

4.8 (0.9–24.9)

4.5 (0.9–23.7)

3.1 (0.6–16.6)

3.2 (0.6–16.7)


30–39

64.0 (14.9–73.9)

18.2 (4.1–82.9)

10.3 (2.0–52.0)

39.1 (7.9–192.7


LDL cholesterol ≥ 130 mg/dl

15–19

1.0

1.0

1.0

1.0


20–29

1.8 (0.9–3.6)

1.8 (0.9–3.5)

1.6 (0.8–3.2)

1.9 (0.9–3.7)


30–39

19.5 (11.0–34.4)

18.2 (9.5–34.8)

17.2 (8.1–36.7)

19.5 (9.7–39.2)


Triglycerides ≥ 150 mg/dl

15–19

1.0

1.0

1.0

1.0


20–29

0.9 (0.4–2.0)

0.9 (0.4–2.0)

0.8 (0.3–1.8)

0.8 (0.4–1.9)


30–39

10.0 (5.5–18.2)

8.5 (4.3–16.6)

7.0 (3.2–15.1)

8.2 (4.0–16.8)


HDL cholesterol < 40 mg/dl

15–19

1.0

1.0

1.0

1.0


20–29

0.8 (0.6–1.0)

0.8 (0.6–1.0)

0.7 (0.5–0.9)

0.7 (0.6–1.1)


30–39

14.1 (7.5–26.7)

11.9 (6.1–23.2)

10.6 (5.2–21.8)

15.8 (7.8–32.0)


Total: HDL cholesterol > 4.5

15–19

1.0

1.0

1.0

1.0


20–29

1.0 (0.9–1.2)

1.0 (0.8–1.2)

0.9 (0.8–1.1)

0.9 (0.8–1.2)


30–39

6.1 (4.5–8.2)

5.9 (4.3–8.3)

5.3 (3.7–7.6)

5.8 (4.1–8.1)


Diabetes

15–19

1.0

1.0

1.0

1.0


20–29

1.0

1.0

1.0

1.0


30–39

17.4 (1.9–156.5)

17.0 (1.3–217.7)

31.6 (0.6–1605.0)

22.0 (1.0–474.5)


Metabolic syndrome

15–19

1.0

1.0

1.0

1.0


20–29

5.7 (0.6–55.3)

5.2 (0.5–51.1)

2.2 (0.2–23.4)

3.0 (0.3–31.0)


30–39

146.2 (19.9–1027.9)

75.1 (9.7–583.9)

19.7 (2.5–155.3)

48.8 (6.3–378.9)


Gupta et al. BMC Cardiovascular Disorders 2009 9:28   doi:10.1186/1471-2261-9-28

Open Data